China VC Tracker China VC Tracker: July Venture Market Continues To Pick Up With $6.54B Invested August 2, 2022 — 13:47
DealShot DealShot: 15 Deals Breaking $310 Million Counting Orbimed, Apricot Capital Among Others March 21, 2022 — 17:48
DealShot DealShot: 16 Deals Passing $230 Million Including CDH Investments, OrbiMed And More March 18, 2022 — 18:35
Led by OrbiMed, HiRO Raised Tens of Millions of US Dollars in Series A Financing, to Offer Multinational Global Clinical Development Strategy March 18, 2022 — 08:00
HanBio Therapeutics Announces the Completion of a US$40 Million Series A Financing Led by OrbiMed and Hankang Capital January 29, 2022 — 11:37
DealShot DealShot: 13 Deals Worth More Than $320 Million With BOCOM International, Orbimed And More December 23, 2021 — 17:01
Zhaoke Ophthalmology’s Phase III Clinical Trial of Cyclosporine A (CsA) Ophthalmic Gel for Dry Eye Disease Meets Primary Endpoint August 19, 2021 — 12:43
Podcasts China Money Podcast: Big Chinese VC Investments In Pharmaceuticals, E-Commerce And Aerospace This Week August 13, 2021 — 23:50
DealShot DealShot: 14 Deals Eclipsing $480 Million With Orbimed, Co-Stone Capital And Many More August 12, 2021 — 17:10
Tech China Tech Digest: Lenovo May Develop Its Own Chips; China’s First NZEB Will Be Put Into Use In Beijing August 12, 2021 — 11:50
Tech China Tech Digest: Miaoshou Doctor Completes $232M Series F Round; Shenzhen Ranks First In The Number Of New Energy Cars August 4, 2021 — 09:37
DealShot DealShot: 15 Deals Exceeding $200 Million Involving OrbiMed, CITIC Capital And More July 28, 2021 — 16:50
DealShot DealShot: 17 Deals Passing $810 Million Counting Orbimed, CITIC PE And Many Others July 23, 2021 — 19:14
Insilico Medicine Raises $255 Million in Series C Financing Led by Warburg Pincus June 22, 2021 — 21:46
EDDA Technology Announces US$150 Million Financing Round, led by Softbank Vision Fund 2, with OrbiMed Participation, to Advance Intelligent Robotic Solutions for Precision Surgery April 7, 2021 — 07:00
DealShot DealShot: 12 Deals Reaching $420 Million Involving OrbiMed, GL Ventures And Others February 24, 2021 — 19:06
DealShot DealShot: 7 Deals Topping $1.75 Billion Including Temasek, OrbiMed And Many Others January 27, 2021 — 14:33
VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China January 9, 2021 — 11:06
DealShot DealShot: 15 Deals Reaching $630 Million Involving HG Capital, OrbiMed And Many More November 18, 2020 — 16:51
DealShot DealShot: 8 Deals Topping $500 Million Involving China Structural Reform Fund, Orbimed Among Others October 30, 2020 — 16:29
Consumer Pet Hospital Chain New Ruipeng Raises Strategic Financing From Tencent September 30, 2020 — 02:09
DealShot DealShot: 5 Deals Breaking $260 Million Including Hudson Bay Capital, OrbiMed And More July 10, 2020 — 16:16
Healthcare Chinese Biotech Startup Harbour BioMed Secures $102.8M In Series C Round July 10, 2020 — 12:50
DealShot DealShot: 6 Deals Topping $2.5 Billion Counting SoftBank Vision Fund, OrbiMed Among Others March 4, 2020 — 16:54
Healthcare SCGC-Backed Innovative Antibody Drug Firm Gets $150M Funding From Sino Biopharm November 5, 2019 — 10:54
Fundraising US, Greater China Healthcare-Focused Vivo Capital Garners $1.28B For Ninth PE Fund June 10, 2019 — 12:49
